Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 Apr 8;3:69–91. doi: 10.2147/ijgm.s8184

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2010 Meltzer et al, publisher and licensee Dove Medical Press Ltd.

This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.

PMC Copyright notice

A) Meta-analysis of intranasal corticosteroids versus oral H₁-receptor antagonists for the treatment of nasal blockage in allergic rhinitis. Intranasal steroids included beclomethasone dipropionate, fluticasone propionate, triamcinolone acetonide, and budesonide. Oral antihistamines included dexchlorpheniramine, terfenadine, astemizole, loratadine, and cetirizine. Adapted with permission from British Medical Journal, Weiner JM, Abramson MJ, Puy RM, volume 317, 1624–1629, Copyright © 1998 with permission from BMJ Publishing Group Ltd.²⁷ B) Meta-analysis of intranasal corticosteroids versus topical H₁-receptor antagonists for the treatment of nasal blockage in allergic rhinitis. Intranasal steroids included beclomethasone dipropionate, fluticasone propionate, and budesonide. Topical antihistamines included azelastine and levocabastine. Adapted with permission from Yáñez A, Rodrigo GJ. Intranasal corticosteroids versus topical H₁ receptor antagonists for the treatment of allergic rhinitis: a systematic review with metaanalysis. Ann Allergy Asthma Immunol. 2002;89(5):479–484.²⁸ Copyright © 2002 American College of Allergy, Asthma and Immunology.